Isabella Marchi

467 total citations
17 papers, 269 citations indexed

About

Isabella Marchi is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Isabella Marchi has authored 17 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Isabella Marchi's work include BRCA gene mutations in cancer (15 papers), Cancer Genomics and Diagnostics (7 papers) and Global Cancer Incidence and Screening (4 papers). Isabella Marchi is often cited by papers focused on BRCA gene mutations in cancer (15 papers), Cancer Genomics and Diagnostics (7 papers) and Global Cancer Incidence and Screening (4 papers). Isabella Marchi collaborates with scholars based in Italy and United States. Isabella Marchi's co-authors include Laura Cortesi, Massimo Federico, Angela Toss, Elisabetta De Matteis, Veronica Medici, Daniela Turchetti, Elisabetta Razzaboni, Claudia Cirilli, Giovanni Tazzioli and Annarita Pecchi and has published in prestigious journals such as Annals of Oncology, International Journal of Cancer and Oncotarget.

In The Last Decade

Isabella Marchi

17 papers receiving 260 citations

Peers

Countries citing papers authored by Isabella Marchi

Since Specialization

Citations

This map shows the geographic impact of Isabella Marchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabella Marchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabella Marchi more than expected).

Fields of papers citing papers by Isabella Marchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabella Marchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabella Marchi. The network helps show where Isabella Marchi may publish in the future.

Co-authorship network of co-authors of Isabella Marchi

This figure shows the co-authorship network connecting the top 25 collaborators of Isabella Marchi. A scholar is included among the top collaborators of Isabella Marchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabella Marchi. Isabella Marchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk 2022 ·JCO Precision Oncology ·Elena Tenedini, Simonetta Piana, Angela Toss, Marco Marino, Elena Barbieri, Lucia Artuso, Marta Venturelli, Elisa Gasparini, Vincenzo Dario Mandato, Isabella Marchi, (unknown), Mario Luppi, Tommaso Trenti, Laura Cortesi, Enrico Tagliafico	3
2	Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 2021 ·Genes ·Angela Toss, Elena Tenedini, (unknown), Marta Venturelli, Isabella Marchi, Elisa Gasparini, Elena Barbieri, Elisabetta Razzaboni, Federica Domati, Federica Caggia, Giovanni Grandi, (unknown), Giovanni Tazzioli, Massimo Dominici, Enrico Tagliafico, Laura Cortesi	20
3	The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study 2021 ·Diagnostics ·Angela Toss, (unknown), Elena Tenedini, Alessandra Bologna, Elisa Gasparini, Vittoria Tarantino, (unknown), (unknown), Filippo Giovanardi, (unknown), Monica Civallero, Luigi Marcheselli, Isabella Marchi, Federica Domati, Marta Venturelli, (unknown), Giovanni Grandi, Enrico Tagliafico, Laura Cortesi	5
4	<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees 2021 ·Cancer Biology and Medicine ·Laura Cortesi, Federica Domati, Annalisa Guida, Isabella Marchi, Angela Toss, Elena Barbieri, Luigi Marcheselli, Marta Venturelli, (unknown), Claudia Cirilli, Massimo Federico	5
5	BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy 2020 ·Cancers ·Angela Toss, Eleonora Molinaro, Marta Venturelli, Federica Domati, Luigi Marcheselli, Simonetta Piana, Elena Barbieri, Giovanni Grandi, (unknown), Isabella Marchi, Elena Tenedini, Enrico Tagliafico, Giovanni Tazzioli, Laura Cortesi	19
6	BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience 2019 ·Annals of Oncology ·Eleonora Molinaro, Marta Venturelli, Angela Toss, (unknown), Elena Barbieri, Luigi Marcheselli, Isabella Marchi, Enrico Tagliafico, Stefano Cascinu, Laura Cortesi	1
7	Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies 2019 ·Cancers ·Angela Toss, Marta Venturelli, Eleonora Molinaro, Stefania Pipitone, Elena Barbieri, Isabella Marchi, Elena Tenedini, Lucia Artuso, (unknown), Marco Marino, Enrico Tagliafico, Elisabetta Razzaboni, Elisabetta De Matteis, Stefano Cascinu, Laura Cortesi	14
8	Breast ultrasonography (BU) in the screening protocol for women at hereditary‐familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories? 2018 ·International Journal of Cancer ·Laura Cortesi, (unknown), (unknown), Annarita Pecchi, (unknown), (unknown), Angela Toss, Elisabetta De Matteis, Isabella Marchi, Pietro Torricelli, Stefano Cascinu	14
9	Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 2017 ·Oncology ·Laura Cortesi, Elisabetta De Matteis, Angela Toss, Isabella Marchi, Veronica Medici, Giannina Contu, Anjeza Xholli, Giovanni Grandi, Angelo Cagnacci, Massimo Federico	21
10	BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype 2017 ·Oncotarget ·Roberta Zuntini, Laura Cortesi, Daniele Calistri, Tommaso Pippucci, Pier Luigi Martelli, Rita Casadio, Elisa Capizzi, Donatella Santini, Sara Miccoli, Veronica Medici, Rita Danesi, Isabella Marchi, Valentina Zampiga, Michelangelo Fiorentino, Simona Ferrari, Daniela Turchetti	12
11	Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass Index at the Modena Screening Program 2016 ·Journal of Breast Cancer ·(unknown), Laura Cortesi, Milena Sant, Valeria Lucarini, Claudia Cirilli, Elisabetta De Matteis, Isabella Marchi, Rossella Negri, (unknown), Massimo Federico	29
12	A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women 2013 ·Annals of Oncology ·Laura Cortesi, Elisabetta Razzaboni, Angela Toss, Elisabetta De Matteis, Isabella Marchi, Veronica Medici, Giovanni Tazzioli, Alessia Andreotti, Giorgio De Santis, Marco Pignatti, Massimo Federico	29
13	Chemoprevention Strategies for High Risk Women 2012 ·Current Women s Health Reviews ·Angela Toss, (unknown), Elisabetta Razzaboni, Elisabetta De Matteis, Isabella Marchi, (unknown), Laura Cortesi	2
14	Acceptability and Adherence in a Chemoprevention Trial among Women at Increased Risk for Breast Cancer Attending the Modena Familial Breast and Ovarian Cancer Center (Italy) 2012 ·The Breast Journal ·Elisabetta Razzaboni, Angela Toss, Laura Cortesi, Isabella Marchi, (unknown), Elisabetta De Matteis, Massimo Federico	23
15	Radiological Screening Programs for Women at High Risk of Developing Breast Cancer 2012 ·Current Women s Health Reviews ·Laura Cortesi, Elisabetta De Matteis, (unknown), Angela Toss, Isabella Marchi, (unknown), (unknown), Annarita Pecchi, Massimo Federico	1
16	Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer 2010 ·BMC Cancer ·Laura Cortesi, Cristina Masini, Claudia Cirilli, Veronica Medici, Isabella Marchi, Giovanna Cavazzini, Elena Pasini, Daniela Turchetti, Massimo Federico	32
17	Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience 2006 ·BMC Cancer ·Laura Cortesi, Daniela Turchetti, Isabella Marchi, (unknown), (unknown), (unknown), Silvia Ruscelli, Annarita Pecchi, Pietro Torricelli, Massimo Federico	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact